|
ISPOR 11th Annual European Congress Summary
Stephen L. Priori, Director, ISPOR Publications
The ISPOR 11th Annual European Congress was held
on 8-11 November 2008 at the Hilton Athens, Athens,
Greece setting another ISPOR record with more than
1900 in attendance.
Uwe Siebert MD, MPH, MSc, ScD, Professor of
Public Health, University of Health Sciences, Medical
Informatics and Technology, Hall/Innsbruck, Austria,
and John Yfantopoulos PhD, Professor of Health
Economics, University of Athens and President of the
National Centre for Social Research, Athens, Greece,
served as the Congress co-chairs providing attendees
with a high-level scientific program.
Sunday 9 November
After the pre-Congress Short Courses Saturday and
Sunday morning, and the opening Poster Session, the
11th European Congress opened with 2008-2009
ISPOR President Chris Pashos PhD, welcomed attendees
to Greece while John Yfantopoulos and Uwe
Siebert introduced the Congress's objectives. The
First Plenary Session “Health Technology Assessment
(HTA) in Europe - Is Harmonization Possible?,”
moderated by Siebert, featured three speakers: Alric
Rüther MD, PhD, Head, Department of Quality of
Health Care, Institute for Quality and |

(l-r): 11th European Congress Co-Chair,
John
Yfantopoulos PhD,
2008-2009 ISPOR President Chris L.
Pashos PhD,
11th European Congress Co-Chair,
Uwe Siebert MPH, MSc |
Efficiency in
Health Care (IQWiG), Cologne, Germany, contended
that harmonization of methods is possible, but not the
processes, leading to the need for exchange and
communication between HTA agencies.Louise
Longworth PhD, Senior Research Fellow, School of
Health & Related Research (ScHARR), University of
Sheffield, Sheffield, UK, discussed HTA from the UK
perspective, in which harmonization can be examined
from underlying principles and processes, appraisal
framework or of methods of assessment. The plenary
concluded with Finn Boerlum Kristensen MD, PhD,
Director & Professor, Danish Centre for Health
Technology Assessment, National Board of Health,
Copenhagen, Denmark; Adjunct Professor, University
of Southern Denmark; Project Leader, European
Network for HTA (EUnetHTA), making the case that
European collaboration on HTA adds value by leading
to more timely, high quality input to health care policy
in member states, the EU and other countries.
Podium Sessions I & II were held on Sunday afternoon
followed by the conclusion of Poster Session I
with its Exhibitors Open House Reception Sunday
evening. The ISPOR Central & Eastern European
Chapters presented their forum Sunday evening as
well.
Monday 10 November
The Second Plenary Session, moderated by John
Yfantopoulos, “Improving Equity of Access to
Pharmaceutical Therapies in Europe, Middle East &
Africa,” offered attendees discussion in three areas:
Health Care Equity Issues In Russia, the Middle East,
and Africa. Oleg Borisenko MD, Executive Director,
Russian Society for Pharmacoeconomics and
Outcomes Research, Moscow, Russia, stated the
need to establish reference prices, a unified list of
essential medicines - the financing priority,, a reimbursement
distribution for all populations; federal
financing for rare, and expensive drugs, and other
patient delivery logistics. Professor Pavel Vorobyev
MD, PhD, Professor, Head, Department of
Hematology and Geriatrics, Moscow Medical
Academy, Moscow, Russia and President ISPOR
Russia Chapter, addressed follow-up questions from
the audience. Dr. Ibrahim Al-Abbadi PhD, MBA,
Assistant Professor, University of Jordan, Faculty of
Pharmacy, Amman, Jordan and President ISPOR
Jordan Chapter summarized the need to develop an
effective pharmaceutical sector as part of strengthened
health system, to ensure good governance in
the health and pharmaceutical sector, to strengthen
the national regulatory authority, to improve the availability,
improved pricing and limitation to generic
drugs in public sector procurement, as well as price
reductions in the private sector; and finally to rationalize
the tax regime and mark-up on medicines. Tienie
Stander MBChB, MBA, Honorary Professor, North
West University, School of Pharmacy, Johannesburg,
South Africa and President, ISPOR South Africa
Chapter concluded with the external sources involved
in health care reform (sector wide approach), tax and
debt relief; mandatory health care insurance (SHI and
NHI); private voluntary insurance (community-based
health insurance), out-of-pocket payments (fee
removal), as well as pharmaceutical reform, that
involves Africa's burden of disease, global R&D, the
cost of new technology drugs, the African Union
response (SADC response, regulatory authority harmonization,
and clinical research manufacturing), and
finally a South African response.
After the Monday morning plenary, the second of
three poster sessions opened followed by
Contributed Podium Sessions III & IV, and the first
of three Issue Panels sessions and four workshop
sessions.
Monday evening ISPOR's attendees dined and
danced at this year's Social Event at the Yacht Club of
Greece. Guests enjoyed mingling inside & the spectacular
views of Athens, Phaleron Bay, the Saronic
Gulf and the islands of Salamis, Aegina and Poros
outside.
Tuesday 11 November
For the first time, the 11th European Congress's final
day was a full day of sessions. The Third Plenary and
the third poster session differentiated it from years
past. Following the morning ISPOR Special Interest
Group and Task Force Forums, Milton Weinstein PhD,
Professor Health Policy and Management, Harvard
School of Public Health, Boston, MA, USA moderated
a lively Third Plenary Session, “Can We Agree on
International Guidelines for Economic Evaluation of
Health Care Interventions?,” The three topics for discussion
were: “Is The Estimation Of Incremental Cost
Per QALY the Answer?” with Michael Drummond PhD,
Professor of Health Economics, Centre for Health
Economics, University of York, Heslington, York, UK,
speaking on the threshold, maximum willingness-topay,
It may be 'kinked' as it passes though the origin,
reflecting individuals' greater reluctance to give up current
benefits and the health care field's relatively few
innovations in this quadrant. “Is Efficiency Frontier
Approach the Answer?” was the response and discussion
from J. Jaime Caro MD, Senior Vice President
of Health Economics, United BioSource Corporation,
Concord MA, USA, who summarized multi-dimensionality
is unavoidable. Real decision-makers prefer
to be informed in full rather than be faced only with an
aggregate measure. An aggregate measure necessarily
conceals relevant details & implications, while
multiple EF plots can be made and provide information
to decision-makers. Uwe Siebert concluded with,
“Why Can't We Work Together?” offering the suggestion
that health economists apply both the cost/QALY
approach and the EF approach to investigate particular
implications of the two methods.
Contributed Poster and Exhibits Session III, Issues
Panel Session III, Workshop Sessions III & IV, followed
the lively Third Plenary session. This European
Congress displayed more than 900 posters, presented
76 podium presentations, 10 Issue Panels, 28
Work Shops, and 6 Forums. With nearly 2000 attendees,
and another entertaining social event, it was
truly a memorable congress.
ISPOR will gather again on May 16-20, 2009 in sunny
Orlando, FL, USA for the ISPOR 14th Annual
International Meeting. We hope to see you there and
thank you for joining us in Athens as the Gods were
pleased!
|